Searched for
APOLLO PHARMA BUSINESS
Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Nifty can rally to 30,089 in Prabhudas Lilladher’s bull case scenario, adds 3 stocks to model portfolioDomestic brokerage Prabhudas Lilladher sees Nifty rallying 24% to 30,089 in a bull-case scenario, driven by strength in banks, capital good...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
- FIIs bought 120 Indian stocks in Q4 amid Rs 1.3 lakh crore exodus. What's special about them?Despite a significant Rs 1.3 lakh cr exodus in Q4, Foreign Institutional Investors selectively increased stakes in 120 Indian stocks. These...
- Pharma and healthcare companies to face continued margin pressure: HDFC SecuritiesThe Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the Marc...
- Apollo Hospitals shares in focus as Q2 PAT rises 26% YoY; Morgan Stanley maintains ‘Overweight’ callApollo Hospitals shares: The company posted a 26% YoY rise in Q2FY26 profit to ₹477 crore, led by robust growth across its hospital, diagno...
- Apollo Hospitals Q2 Results: PAT rises 26% YoY to Rs 477 croreApollo Hospitals Enterprise reported a strong Q2FY26 with a 26% YoY rise in profit after tax to Rs 477 crore, driven by broad-based growth ...
- Drug companies set for improved revenue growth in June quarter amid US market challengesIndian pharma and healthcare companies anticipate improved revenue and profit in the June 2025 quarter, fueled by domestic market growth. H...
- Apollo Hospitals to spin off digi health, pharmacy businessApollo Hospitals is demerging its omnichannel pharma and digital health businesses into a new entity, aiming for a separate listing. This m...
- Apollo Hospitals to hive-off pharmacy, digital health businessesApollo Hospitals Enterprise has announced the separate listing of its omnichannel pharmacy and digital health businesses within 18-21 month...
- CCI clears Rs 4,630 cr deal between Warburg Pincus, Shriram Housing FinanceThe Competition Commission of India (CCI) has approved Warburg Pincus' acquisition of Shriram Housing Finance through its affiliate Mango C...
- Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan CompanyTop brokerage firms like Macquarie maintained an outperform rating on Aurobindo Pharma, raising the target price to Rs 1,385. Aurobindo Pha...
- Stocks in news: PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, CiplaBenchmark equities surged for the third consecutive day on Tuesday. PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, and Cipla...
- Apollo Hospitals' pharma business rejig gets CCI clearanceThe move followed a review of long-term strategy for both health care services and standalone pharmacies of the company.
- Apollo Hospitals reshuffling its top deckApollo Hospitals, the country’s biggest healthcare chain, is reshuffling its top deck with a clutch of executives as the family-run enterpr...
Load More
